| 1 | VRTX | Vertex Pharmaceuticals Incorporated | $113.64B | +0.64% |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | $78.80B | -0.99% |
| 3 | ARGX | argenx SE | $49.22B | +1.97% |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | $42.61B | -1.82% |
| 5 | ONC | BeOne Medicines AG | $34.75B | +0.39% |
| 6 | INSM | Insmed Incorporated | $34.45B | -0.37% |
| 7 | RPRX | Royalty Pharma plc | $27.86B | +0.84% |
| 8 | BNTX | BioNTech SE | $23.26B | -0.11% |
| 9 | ROIV | Roivant Sciences Ltd. | $20.38B | +1.10% |
| 10 | MRNA | Moderna, Inc. | $20.34B | -1.57% |
| 11 | INCY | Incyte Corporation | $19.30B | +1.12% |
| 12 | RVMD | Revolution Medicines, Inc. | $19.07B | -0.55% |
| 13 | GMAB | Genmab A/S | $17.32B | -0.42% |
| 14 | SMMT | Summit Therapeutics Inc. | $14.97B | +2.66% |
| 15 | ASND | Ascendis Pharma A/S | $14.93B | +3.65% |
| 16 | BBIO | BridgeBio Pharma, Inc. | $14.64B | +1.86% |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | $12.63B | +1.93% |
| 18 | JAZZ | Jazz Pharmaceuticals plc | $12.20B | +1.13% |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | $12.03B | +0.88% |
| 20 | EXEL | Exelixis, Inc. | $11.79B | +2.73% |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | $10.83B | -1.57% |
| 22 | ABVX | ABIVAX Société Anonyme | $9.77B | +5.66% |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | $9.27B | +2.91% |
| 24 | AXSM | Axsome Therapeutics, Inc. | $9.15B | +3.30% |
| 25 | PRAX | Praxis Precision Medicines, Inc. | $8.92B | +0.01% |
| 26 | PCVX | Vaxcyte, Inc. | $8.88B | +2.65% |
| 27 | TECH | Bio-Techne Corporation | $8.69B | +0.65% |
| 28 | NUVL | Nuvalent, Inc. | $8.22B | -0.43% |
| 29 | CYTK | Cytokinetics, Incorporated | $7.96B | -1.79% |
| 30 | HALO | Halozyme Therapeutics, Inc. | $7.95B | +2.52% |
| 31 | IBRX | ImmunityBio, Inc. | $7.72B | +7.16% |
| 32 | KRYS | Krystal Biotech, Inc. | $7.60B | -2.23% |
| 33 | BLTE | Belite Bio, Inc | $7.13B | +1.44% |
| 34 | KYMR | Kymera Therapeutics, Inc. | $7.13B | +0.25% |
| 35 | ACLX | Arcellx, Inc. | $6.74B | +0.01% |
| 36 | PTGX | Protagonist Therapeutics, Inc. | $6.64B | +1.95% |
| 37 | APGE | Apogee Therapeutics, Inc. | $6.39B | +4.09% |
| 38 | CNTA | Centessa Pharmaceuticals plc | $6.15B | +0.58% |
| 39 | TERN | Terns Pharmaceuticals, Inc. | $6.07B | -0.19% |
| 40 | CELC | Celcuity Inc. | $6.02B | +6.58% |
| 41 | COGT | Cogent Biosciences, Inc. | $6.02B | +1.08% |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | $5.97B | +1.02% |
| 43 | RYTM | Rhythm Pharmaceuticals, Inc. | $5.88B | +0.76% |
| 44 | PTCT | PTC Therapeutics, Inc. | $5.86B | -0.58% |
| 45 | CGON | CG Oncology, Inc. | $5.79B | -0.45% |
| 46 | SRRK | Scholar Rock Holding Corporation | $5.65B | -1.60% |
| 47 | XENE | Xenon Pharmaceuticals Inc. | $5.59B | +1.82% |
| 48 | CAI | Caris Life Sciences, Inc. | $5.43B | -1.59% |
| 49 | ERAS | Erasca, Inc. | $5.40B | +2.48% |
| 50 | IMVT | Immunovant, Inc. | $5.22B | +3.72% |
| 51 | APLS | Apellis Pharmaceuticals, Inc. | $5.20B | -0.10% |
| 52 | TGTX | TG Therapeutics, Inc. | $5.11B | +1.23% |
| 53 | CRSP | CRISPR Therapeutics AG | $4.96B | -0.08% |
| 54 | DNTH | Dianthus Therapeutics, Inc. | $4.85B | +4.78% |
| 55 | FOLD | Amicus Therapeutics, Inc. | $4.54B | +0.07% |
| 56 | CORT | Corcept Therapeutics Incorporated | $4.49B | +0.91% |
| 57 | CRNX | Crinetics Pharmaceuticals, Inc. | $4.15B | -0.83% |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | $4.10B | -1.18% |
| 59 | SYRE | Spyre Therapeutics, Inc. | $4.07B | -0.40% |
| 60 | VKTX | Viking Therapeutics, Inc. | $4.05B | +3.80% |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | $4.03B | +3.12% |
| 62 | GPCR | Structure Therapeutics Inc. | $3.91B | +3.82% |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | $3.85B | +0.04% |
| 64 | EWTX | Edgewise Therapeutics, Inc. | $3.60B | +1.45% |
| 65 | LEGN | Legend Biotech Corporation | $3.37B | -0.55% |
| 66 | TLX | Telix Pharmaceuticals Limited | $3.27B | +0.20% |
| 67 | DYN | Dyne Therapeutics, Inc. | $3.19B | +5.33% |
| 68 | ORKA | Oruka Therapeutics, Inc. | $3.15B | +2.56% |
| 69 | CPRX | Catalyst Pharmaceuticals, Inc. | $3.13B | +1.15% |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | $3.08B | +0.74% |
| 71 | DNLI | Denali Therapeutics Inc. | $3.06B | -1.68% |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | $3.05B | -0.16% |
| 73 | TNGX | Tango Therapeutics, Inc. | $2.95B | +3.19% |
| 74 | VERA | Vera Therapeutics, Inc. | $2.92B | +1.49% |
| 75 | RCUS | Arcus Biosciences, Inc. | $2.92B | +2.78% |
| 76 | ALMS | Alumis Inc. | $2.92B | +1.01% |
| 77 | TVTX | Travere Therapeutics, Inc. | $2.90B | -0.76% |
| 78 | ELVN | Enliven Therapeutics, Inc. | $2.73B | +6.20% |
| 79 | IDYA | IDEAYA Biosciences, Inc. | $2.72B | +0.13% |
| 80 | SLNO | Soleno Therapeutics, Inc. | $2.72B | -0.17% |
| 81 | RLAY | Relay Therapeutics, Inc. | $2.68B | +3.38% |
| 82 | CLDX | Celldex Therapeutics, Inc. | $2.64B | +3.73% |
| 83 | BEAM | Beam Therapeutics Inc. | $2.61B | +3.50% |
| 84 | KOD | Kodiak Sciences Inc. | $2.61B | +1.34% |
| 85 | IRON | Disc Medicine, Inc. | $2.57B | +1.55% |
| 86 | IMNM | Immunome, Inc. | $2.54B | +3.50% |
| 87 | ADMA | ADMA Biologics, Inc. | $2.37B | +1.12% |
| 88 | RARE | Ultragenyx Pharmaceutical Inc. | $2.35B | +3.28% |
| 89 | ZLAB | Zai Lab Limited | $2.34B | -3.04% |
| 90 | SRPT | Sarepta Therapeutics, Inc. | $2.33B | +1.51% |
| 91 | AAPG | Ascentage Pharma Group International | $2.32B | -2.56% |
| 92 | MANE | Veradermics, Incorporated | $2.24B | +3.34% |
| 93 | MLYS | Mineralys Therapeutics, Inc. | $2.24B | -2.13% |
| 94 | NKTR | Nektar Therapeutics | $2.23B | +3.69% |
| 95 | DAWN | Day One Biopharmaceuticals, Inc. | $2.22B | +0.19% |
| 96 | SNDX | Syndax Pharmaceuticals, Inc. | $2.18B | +0.81% |
| 97 | DFTX | Definium Therapeutics, Inc. | $2.14B | +1.90% |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | $2.12B | +0.44% |
| 99 | STOK | Stoke Therapeutics, Inc. | $2.08B | +0.80% |
| 100 | ADPT | Adaptive Biotechnologies Corporation | $2.06B | -9.70% |
| 101 | OCUL | Ocular Therapeutix, Inc. | $2.02B | +10.45% |
| 102 | ZYME | Zymeworks Inc. | $2.02B | +2.40% |
| 103 | TYRA | Tyra Biosciences, Inc. | $1.98B | -1.19% |
| 104 | ANAB | AnaptysBio, Inc. | $1.97B | +4.58% |
| 105 | AGIO | Agios Pharmaceuticals, Inc. | $1.93B | -2.52% |
| 106 | GLPG | Galapagos NV | $1.88B | -1.14% |
| 107 | PVLA | Palvella Therapeutics, Inc. | $1.86B | +5.71% |
| 108 | MESO | Mesoblast Limited | $1.85B | +4.53% |
| 109 | CAPR | Capricor Therapeutics, Inc. | $1.82B | +0.03% |
| 110 | INVA | Innoviva, Inc. | $1.79B | +2.46% |
| 111 | PHVS | Pharvaris N.V. | $1.77B | -1.78% |
| 112 | SION | Sionna Therapeutics, Inc. | $1.75B | +5.25% |
| 113 | RXRX | Recursion Pharmaceuticals, Inc. | $1.75B | -2.36% |
| 114 | VCEL | Vericel Corporation | $1.71B | -1.29% |
| 115 | TRVI | Trevi Therapeutics, Inc. | $1.71B | +1.76% |
| 116 | HRMY | Harmony Biosciences Holdings, Inc. | $1.69B | +2.42% |
| 117 | NRIX | Nurix Therapeutics, Inc. | $1.68B | +4.10% |
| 118 | IOVA | Iovance Biotherapeutics, Inc. | $1.65B | +15.56% |
| 119 | RAPP | Rapport Therapeutics, Inc. | $1.64B | +1.57% |
| 120 | NTLA | Intellia Therapeutics, Inc. | $1.63B | -0.29% |
| 121 | IMCR | Immunocore Holdings plc | $1.61B | -0.13% |
| 122 | DMRA | Damora Therapeutics, Inc. | $1.61B | +4.26% |
| 123 | OCS | Oculis Holding AG | $1.61B | -0.55% |
| 124 | NUVB | Nuvation Bio Inc. | $1.59B | +2.21% |
| 125 | VRDN | Viridian Therapeutics, Inc. | $1.57B | +6.29% |
| 126 | VIR | Vir Biotechnology, Inc. | $1.57B | +3.26% |
| 127 | MBX | MBX Biosciences, Inc. | $1.56B | +3.79% |
| 128 | PGEN | Precigen, Inc. | $1.51B | +3.64% |
| 129 | ARDX | Ardelyx, Inc. | $1.50B | +0.49% |
| 130 | SVRA | Savara Inc. | $1.49B | -1.18% |
| 131 | GENB | Generate Biomedicines, Inc. | $1.47B | -3.43% |
| 132 | NBTX | Nanobiotix S.A. | $1.46B | -0.97% |
| 133 | OLMA | Olema Pharmaceuticals, Inc. | $1.45B | +6.05% |
| 134 | GLUE | Monte Rosa Therapeutics, Inc. | $1.44B | +5.43% |
| 135 | BCAX | Bicara Therapeutics Inc. | $1.44B | +1.71% |
| 136 | IMTX | Immatics N.V. | $1.43B | +1.23% |
| 137 | BHVN | Biohaven Ltd. | $1.41B | +0.11% |
| 138 | MLTX | MoonLake Immunotherapeutics | $1.39B | +4.35% |
| 139 | NVAX | Novavax, Inc. | $1.39B | +1.43% |
| 140 | MAZE | Maze Therapeutics, Inc. | $1.39B | -0.75% |
| 141 | ATAI | AtaiBeckley Inc. | $1.35B | -1.60% |
| 142 | WVE | Wave Life Sciences Ltd. | $1.35B | +0.85% |
| 143 | TSHA | Taysha Gene Therapies, Inc. | $1.33B | +1.76% |
| 144 | CRVS | Corvus Pharmaceuticals, Inc. | $1.32B | +5.31% |
| 145 | MPLT | MapLight Therapeutics, Inc. | $1.29B | +21.33% |
| 146 | ZBIO | Zenas BioPharma, Inc. | $1.27B | +2.01% |
| 147 | AVBP | ArriVent BioPharma, Inc. | $1.20B | +7.92% |
| 148 | PHAR | Pharming Group N.V. | $1.20B | — |
| 149 | EYPT | EyePoint, Inc. | $1.19B | +0.42% |
| 150 | DBVT | DBV Technologies S.A. | $1.17B | -0.51% |
| 151 | GERN | Geron Corporation | $1.13B | +2.92% |
| 152 | SEPN | Septerna, Inc. | $1.12B | +1.39% |
| 153 | INBX | Inhibrx Biosciences, Inc. | $1.11B | +12.84% |
| 154 | ABCL | AbCellera Biologics Inc. | $1.04B | +0.29% |
| 155 | ORIC | ORIC Pharmaceuticals, Inc. | $1.04B | +14.70% |
| 156 | XERS | Xeris Biopharma Holdings, Inc. | $1.04B | +1.52% |
| 157 | EVMN | Evommune, Inc. | $1.03B | +5.60% |
| 158 | KALV | KalVista Pharmaceuticals, Inc. | $1.02B | +3.53% |
| 159 | QURE | uniQure N.V. | $1.02B | +2.58% |
| 160 | PHAT | Phathom Pharmaceuticals, Inc. | $1.00B | +7.03% |
| 161 | URGN | UroGen Pharma Ltd. | $999.5M | +7.49% |
| 162 | ANNX | Annexon, Inc. | $985.3M | +1.49% |
| 163 | CMPX | Compass Therapeutics, Inc. | $981.5M | +0.93% |
| 164 | IVA | Inventiva S.A. | $980.0M | +2.94% |
| 165 | AKTS | Aktis Oncology, Inc. | $976.7M | +4.06% |
| 166 | GHRS | GH Research PLC | $947.2M | +1.87% |
| 167 | CGEM | Cullinan Therapeutics, Inc. | $920.6M | +1.67% |
| 168 | XNCR | Xencor, Inc. | $918.9M | +2.29% |
| 169 | CTMX | CytomX Therapeutics, Inc. | $916.6M | -0.24% |
| 170 | SLS | SELLAS Life Sciences Group, Inc. | $906.9M | +3.91% |
| 171 | JBIO | Jade Biosciences, Inc. | $899.0M | +8.77% |
| 172 | JANX | Janux Therapeutics, Inc. | $883.9M | — |
| 173 | FTRE | Fortrea Holdings Inc. | $877.5M | -2.54% |
| 174 | OMER | Omeros Corporation | $857.5M | +3.48% |
| 175 | TBPH | Theravance Biopharma, Inc. | $852.2M | -0.30% |
| 176 | VOR | Vor Biopharma Inc. | $845.3M | -0.92% |
| 177 | ABUS | Arbutus Biopharma Corporation | $840.6M | -1.83% |
| 178 | SANA | Sana Biotechnology, Inc. | $832.6M | -2.80% |
| 179 | SPRY | ARS Pharmaceuticals, Inc. | $821.2M | +0.98% |
| 180 | DRUG | Bright Minds Biosciences Inc. | $805.6M | +3.81% |
| 181 | MRVI | Maravai LifeSciences Holdings, Inc. | $799.5M | — |
| 182 | RLMD | Relmada Therapeutics, Inc. | $798.2M | +8.56% |
| 183 | SLDB | Solid Biosciences Inc. | $797.0M | +1.00% |
| 184 | MNKD | MannKind Corporation | $788.7M | -1.92% |
| 185 | KURA | Kura Oncology, Inc. | $781.7M | +0.68% |
| 186 | DSGN | Design Therapeutics, Inc. | $770.3M | -1.42% |
| 187 | MGTX | MeiraGTx Holdings plc | $760.7M | -0.53% |
| 188 | TENX | Tenax Therapeutics, Inc. | $752.5M | -0.60% |
| 189 | LXRX | Lexicon Pharmaceuticals, Inc. | $745.7M | +5.39% |
| 190 | ANRO | Alto Neuroscience, Inc. | $715.6M | +3.18% |
| 191 | ARVN | Arvinas, Inc. | $714.4M | -0.36% |
| 192 | ALLO | Allogene Therapeutics, Inc. | $709.4M | +7.78% |
| 193 | SGP | SpyGlass Pharma, Inc. | $709.3M | -4.50% |
| 194 | BBOT | BridgeBio Oncology Therapeutics, Inc. | $708.7M | +2.49% |
| 195 | LBRX | LB Pharmaceuticals Inc | $665.1M | +1.19% |
| 196 | GYRE | Gyre Therapeutics, Inc. | $661.1M | +2.12% |
| 197 | DRTS | Alpha Tau Medical Ltd. | $646.9M | +2.08% |
| 198 | FBRX | Forte Biosciences, Inc. | $636.2M | +29.04% |
| 199 | CBIO | Crescent Biopharma, Inc. | $634.4M | +4.26% |
| 200 | OCGN | Ocugen, Inc. | $631.9M | +0.54% |
| 201 | PRME | Prime Medicine, Inc. | $621.5M | -0.85% |
| 202 | MDXG | MiMedx Group, Inc. | $598.7M | +1.51% |
| 203 | TECX | Tectonic Therapeutic, Inc. | $583.8M | +3.43% |
| 204 | CRMD | CorMedix Inc. | $581.8M | +1.80% |
| 205 | KYTX | Kyverna Therapeutics, Inc. | $579.2M | +3.90% |
| 206 | PROK | ProKidney Corp. | $573.6M | +2.70% |
| 207 | ZVRA | Zevra Therapeutics, Inc. | $570.1M | +1.25% |
| 208 | PRTA | Prothena Corporation plc | $569.5M | -0.66% |
| 209 | ACRS | Aclaris Therapeutics, Inc. | $567.1M | +3.29% |
| 210 | UPB | Upstream Bio, Inc. | $567.1M | +5.89% |
| 211 | RIGL | Rigel Pharmaceuticals, Inc. | $563.6M | +2.62% |
| 212 | LYEL | Lyell Immunopharma, Inc. | $556.4M | +4.10% |
| 213 | VALN | Valneva SE | $534.6M | -1.76% |
| 214 | ZURA | Zura Bio Limited | $531.3M | -1.75% |
| 215 | STTK | Shattuck Labs, Inc. | $529.6M | +5.41% |
| 216 | LRMR | Larimar Therapeutics, Inc. | $528.8M | — |
| 217 | FULC | Fulcrum Therapeutics, Inc. | $526.8M | +0.13% |
| 218 | IMMX | Immix Biopharma, Inc. | $516.9M | +11.43% |
| 219 | TRDA | Entrada Therapeutics, Inc. | $505.8M | -1.89% |
| 220 | IVVD | Invivyd, Inc. | $503.4M | +31.85% |
| 221 | FDMT | 4D Molecular Therapeutics, Inc. | $502.4M | -2.57% |
| 222 | AGMB | AgomAb Therapeutics NV | $497.6M | +3.65% |
| 223 | VSTM | Verastem, Inc. | $491.0M | +2.57% |
| 224 | REPL | Replimune Group, Inc. | $488.0M | +0.42% |
| 225 | EIKN | Eikon Therapeutics, Inc. | $487.8M | -5.16% |
| 226 | ENGN | enGene Holdings Inc. | $487.0M | -0.55% |
| 227 | CTNM | Contineum Therapeutics, Inc. | $479.0M | +0.31% |
| 228 | ADCT | ADC Therapeutics SA | $477.7M | +0.80% |
| 229 | LXEO | Lexeo Therapeutics, Inc. | $476.4M | -0.16% |
| 230 | ASMB | Assembly Biosciences, Inc. | $473.5M | +1.70% |
| 231 | AVIR | Atea Pharmaceuticals, Inc. | $465.3M | -1.52% |
| 232 | VTVT | vTv Therapeutics Inc. | $462.9M | -3.02% |
| 233 | RGNX | REGENXBIO Inc. | $462.5M | +3.34% |
| 234 | ABSI | Absci Corporation | $451.4M | -1.34% |
| 235 | STRO | Sutro Biopharma, Inc. | $443.3M | -1.07% |
| 236 | ANL | Adlai Nortye Ltd. | $442.8M | -0.25% |
| 237 | ALT | Altimmune, Inc. | $439.8M | +0.30% |
| 238 | XOMA | XOMA Royalty Corporation | $438.0M | +6.06% |
| 239 | AURA | Aura Biosciences, Inc. | $434.9M | +0.15% |
| 240 | EPRX | Eupraxia Pharmaceuticals Inc. | $433.8M | +2.91% |
| 241 | VNDA | Vanda Pharmaceuticals Inc. | $433.3M | +0.55% |
| 242 | ARMP | Armata Pharmaceuticals, Inc. | $422.4M | -4.87% |
| 243 | YDES | YD Bio Limited | $407.9M | +0.69% |
| 244 | IPSC | Century Therapeutics, Inc. | $406.2M | -1.31% |
| 245 | ENTA | Enanta Pharmaceuticals, Inc. | $404.8M | +1.31% |
| 246 | PBYI | Puma Biotechnology, Inc. | $396.8M | +3.86% |
| 247 | RCKT | Rocket Pharmaceuticals, Inc. | $392.8M | — |
| 248 | IRD | Opus Genetics, Inc. | $391.3M | +6.80% |
| 249 | AUTL | Autolus Therapeutics plc | $391.2M | -1.34% |
| 250 | MNPR | Monopar Therapeutics Inc. | $387.6M | -0.19% |
| 251 | PRTC | PureTech Health plc | $387.5M | +4.65% |
| 252 | NAUT | Nautilus Biotechnology, Inc. | $384.8M | -2.88% |
| 253 | CLYM | Climb Bio, Inc. | $384.5M | +13.38% |
| 254 | OVID | Ovid Therapeutics Inc. | $379.8M | +10.77% |
| 255 | RZLT | Rezolute, Inc. | $379.1M | +2.53% |
| 256 | NMRA | Neumora Therapeutics, Inc. | $378.6M | -4.59% |
| 257 | BNTC | Benitec Biopharma Inc. | $377.5M | -0.36% |
| 258 | DNA | Ginkgo Bioworks Holdings, Inc. | $374.3M | -6.54% |
| 259 | LCTX | Lineage Cell Therapeutics, Inc. | $371.1M | -3.25% |
| 260 | XFOR | X4 Pharmaceuticals, Inc. | $370.0M | +0.49% |
| 261 | IMRX | Immuneering Corporation | $365.9M | +2.91% |
| 262 | PRLD | Prelude Therapeutics Incorporated | $363.1M | +4.27% |
| 263 | NAGE | Niagen Bioscience, Inc. | $359.5M | -2.61% |
| 264 | GLSI | Greenwich LifeSciences, Inc. | $357.7M | +6.69% |
| 265 | CABA | Cabaletta Bio, Inc. | $352.9M | +2.59% |
| 266 | CADL | Candel Therapeutics, Inc. | $351.6M | -3.03% |
| 267 | BCYC | Bicycle Therapeutics plc | $346.4M | -0.40% |
| 268 | NGEN | NervGen Pharma Corp. | $340.7M | +0.72% |
| 269 | ACIU | AC Immune SA | $337.3M | +5.92% |
| 270 | DMAC | DiaMedica Therapeutics Inc. | $333.0M | -0.16% |
| 271 | NGNE | Neurogene Inc. | $332.8M | -1.11% |
| 272 | PALI | Palisade Bio, Inc. | $331.5M | +5.88% |
| 273 | AVTX | Avalo Therapeutics, Inc. | $323.8M | -1.39% |
| 274 | SRZN | Surrozen, Inc. | $315.3M | +5.86% |
| 275 | ZNTL | Zentalis Pharmaceuticals, Inc. | $313.5M | +60.14% |
| 276 | ABEO | Abeona Therapeutics Inc. | $292.1M | +5.13% |
| 277 | LENZ | LENZ Therapeutics, Inc. | $291.3M | -1.69% |
| 278 | IKT | Inhibikase Therapeutics, Inc. | $288.0M | -2.87% |
| 279 | TARA | Protara Therapeutics, Inc. | $287.2M | +1.72% |
| 280 | EDIT | Editas Medicine, Inc. | $282.9M | +4.71% |
| 281 | AVXL | Anavex Life Sciences Corp. | $282.6M | +0.33% |
| 282 | NBP | NovaBridge Biosciences | $281.7M | -0.82% |
| 283 | FHTX | Foghorn Therapeutics Inc. | $281.2M | -2.04% |
| 284 | CCCC | C4 Therapeutics, Inc. | $276.1M | -2.41% |
| 285 | SLN | Silence Therapeutics plc | $274.0M | -0.85% |
| 286 | PLYX | Polaryx Therapeutics, Inc. | $272.7M | +0.35% |
| 287 | SABS | SAB Biotherapeutics, Inc. | $269.2M | +2.68% |
| 288 | ALEC | Alector, Inc. | $264.9M | -0.83% |
| 289 | HELP | Cybin Inc. | $262.2M | -0.19% |
| 290 | NERV | Minerva Neurosciences, Inc. | $260.5M | +11.07% |
| 291 | CLLS | Cellectis S.A. | $257.8M | -0.85% |
| 292 | ADAG | Adagene Inc. | $254.1M | -3.87% |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | $247.5M | -0.94% |
| 294 | CHRS | Coherus Oncology, Inc. | $247.3M | -2.94% |
| 295 | MIST | Milestone Pharmaceuticals Inc. | $246.5M | +12.92% |
| 296 | KROS | Keros Therapeutics, Inc. | $246.3M | -0.48% |
| 297 | SLGL | Sol-Gel Technologies Ltd. | $239.6M | -1.62% |
| 298 | CNTX | Context Therapeutics Inc. | $238.0M | -1.89% |
| 299 | VYGR | Voyager Therapeutics, Inc. | $236.0M | +1.02% |
| 300 | ELDN | Eledon Pharmaceuticals, Inc. | $235.5M | -0.96% |
| 301 | CGEN | Compugen Ltd. | $234.5M | +8.30% |
| 302 | ARCT | Arcturus Therapeutics Holdings Inc. | $233.6M | -3.29% |
| 303 | CAMP | Camp4 Therapeutics Corporation | $233.1M | -1.97% |
| 304 | MDWD | MediWound Ltd. | $228.4M | +2.90% |
| 305 | ENLV | Enlivex Ltd. | $225.4M | +1.77% |
| 306 | ALXO | ALX Oncology Holdings Inc. | $223.7M | -10.29% |
| 307 | FENC | Fennec Pharmaceuticals Inc. | $220.6M | -1.39% |
| 308 | MGNX | MacroGenics, Inc. | $218.6M | -0.29% |
| 309 | CDXS | Codexis, Inc. | $218.1M | +8.60% |
| 310 | OABI | OmniAb, Inc. | $217.9M | -0.99% |
| 311 | NVCT | Nuvectis Pharma, Inc. | $216.2M | +0.25% |
| 312 | PRQR | ProQR Therapeutics N.V. | $208.6M | +8.20% |
| 313 | MENS | Jyong Biotech Ltd. | $206.1M | — |
| 314 | CNTN | Canton Strategic Holdings, Inc. | $192.6M | +3.66% |
| 315 | CRBU | Caribou Biosciences, Inc. | $189.4M | +0.51% |
| 316 | ELTX | Elicio Therapeutics, Inc. | $189.3M | +1.58% |
| 317 | KRRO | Korro Bio, Inc. | $188.7M | -2.82% |
| 318 | TNXP | Tonix Pharmaceuticals Holding Corp. | $184.7M | -0.31% |
| 319 | KPTI | Karyopharm Therapeutics Inc. | $183.9M | +12.55% |
| 320 | SGMT | Sagimet Biosciences Inc. | $183.8M | +0.89% |
| 321 | PLX | Protalix BioTherapeutics, Inc. | $183.7M | +1.33% |
| 322 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | $183.0M | +4.88% |
| 323 | ABOS | Acumen Pharmaceuticals, Inc. | $181.3M | -2.71% |
| 324 | ACHV | Achieve Life Sciences, Inc. | $176.8M | +1.84% |
| 325 | AGEN | Agenus Inc. | $170.9M | +5.95% |
| 326 | DTIL | Precision BioSciences, Inc. | $170.6M | +10.35% |
| 327 | IMUX | Immunic, Inc. | $168.3M | +8.40% |
| 328 | ARTV | Artiva Biotherapeutics, Inc. | $168.1M | +9.85% |
| 329 | UNCY | Unicycive Therapeutics, Inc. | $167.8M | +3.10% |
| 330 | WHWK | Whitehawk Therapeutics, Inc. | $167.6M | +4.11% |
| 331 | NKTX | Nkarta, Inc. | $166.8M | +1.30% |
| 332 | RNAC | Cartesian Therapeutics, Inc. | $163.8M | +0.49% |
| 333 | MOLN | Molecular Partners AG | $161.0M | +2.17% |
| 334 | SPRO | Spero Therapeutics, Inc. | $160.9M | +2.21% |
| 335 | TLSA | Tiziana Life Sciences Ltd | $160.8M | -0.79% |
| 336 | TNYA | Tenaya Therapeutics, Inc. | $160.6M | +2.04% |
| 337 | GALT | Galectin Therapeutics Inc. | $160.0M | +9.46% |
| 338 | CNTB | Connect Biopharma Holdings Limited | $157.1M | +5.70% |
| 339 | HRTX | Heron Therapeutics, Inc. | $154.5M | -1.51% |
| 340 | BDTX | Black Diamond Therapeutics, Inc. | $147.8M | +3.20% |
| 341 | FATE | Fate Therapeutics, Inc. | $147.7M | +7.63% |
| 342 | ORMP | Oramed Pharmaceuticals Inc. | $142.8M | +1.44% |
| 343 | KLRS | Kalaris Therapeutics, Inc. | $139.2M | -4.26% |
| 344 | ACOG | Alpha Cognition Inc. | $138.7M | -3.99% |
| 345 | HUMA | Humacyte, Inc. | $134.8M | -6.83% |
| 346 | BMEA | Biomea Fusion, Inc. | $133.8M | +5.11% |
| 347 | IPHA | Innate Pharma S.A. | $128.4M | — |
| 348 | HURA | TuHURA Biosciences, Inc. | $124.6M | +8.29% |
| 349 | NTHI | NeOnc Technologies Holdings, Inc. | $121.9M | -4.66% |
| 350 | ONCY | Oncolytics Biotech Inc. | $120.8M | +14.80% |
| 351 | EQ | Equillium, Inc. | $120.8M | +6.11% |
| 352 | CRDF | Cardiff Oncology, Inc. | $114.2M | +7.05% |
| 353 | GNLX | Genelux Corporation | $113.6M | -3.03% |
| 354 | PMN | ProMIS Neurosciences, Inc. | $112.1M | +16.82% |
| 355 | PEPG | PepGen Inc. | $111.3M | -3.01% |
| 356 | ANTX | AN2 Therapeutics, Inc. | $109.6M | -8.68% |
| 357 | SGMO | Sangamo Therapeutics, Inc. | $108.5M | +2.83% |
| 358 | COYA | Coya Therapeutics, Inc. | $106.3M | +10.22% |
| 359 | TTRX | Turn Therapeutics Inc. | $104.6M | +0.29% |
| 360 | KZIA | Kazia Therapeutics Limited | $104.0M | — |
| 361 | PYXS | Pyxis Oncology, Inc. | $101.2M | +9.52% |
| 362 | VRCA | Verrica Pharmaceuticals Inc. | $100.2M | +0.17% |
| 363 | EXOZ | eXoZymes, Inc. | $96.7M | +9.09% |
| 364 | CBUS | Cibus, Inc. | $96.0M | -13.99% |
| 365 | ALDX | Aldeyra Therapeutics, Inc. | $95.7M | +1.27% |
| 366 | SEER | Seer, Inc. | $94.5M | -0.89% |
| 367 | ANIX | Anixa Biosciences, Inc. | $91.9M | +0.37% |
| 368 | SPRB | Spruce Biosciences, Inc. | $90.6M | +3.71% |
| 369 | LONA | LeonaBio, Inc. | $89.6M | -0.42% |
| 370 | VANI | Vivani Medical, Inc. | $88.0M | -1.89% |
| 371 | GOSS | Gossamer Bio, Inc. | $87.2M | +6.97% |
| 372 | INO | Inovio Pharmaceuticals, Inc. | $85.7M | -3.67% |
| 373 | AARD | Aardvark Therapeutics, Inc. | $85.1M | -0.76% |
| 374 | PLRX | Pliant Therapeutics, Inc. | $83.9M | -0.37% |
| 375 | MCRB | Seres Therapeutics, Inc. | $83.5M | -0.57% |
| 376 | FLNA | Filana Therapeutics, Inc. | $83.1M | +1.18% |
| 377 | OKYO | OKYO Pharma Limited | $82.9M | -0.63% |
| 378 | PYPD | PolyPid Ltd. | $82.1M | +1.65% |
| 379 | NRXS | NeurAxis, Inc. | $81.1M | +2.11% |
| 380 | CSBR | Champions Oncology, Inc. | $79.8M | -4.64% |
| 381 | ESLA | Estrella Immunopharma, Inc. | $78.9M | -3.65% |
| 382 | COEP | Coeptis Therapeutics Holdings, Inc. | $78.5M | +16.31% |
| 383 | RANI | Rani Therapeutics Holdings, Inc. | $77.8M | -6.15% |
| 384 | GANX | Gain Therapeutics, Inc. | $77.7M | +2.22% |
| 385 | FBIO | Fortress Biotech, Inc. | $77.3M | +3.90% |
| 386 | CGTX | Cognition Therapeutics, Inc. | $76.9M | -2.27% |
| 387 | IBO | Impact BioMedical Inc. | $76.5M | — |
| 388 | IBIO | iBio, Inc. | $76.0M | -1.79% |
| 389 | PTHS | Pelthos Therapeutics Inc. | $75.8M | -1.40% |
| 390 | NRXP | NRx Pharmaceuticals, Inc. | $74.7M | +0.44% |
| 391 | GUTS | Fractyl Health, Inc. | $74.5M | +1.01% |
| 392 | IFRX | InflaRx N.V. | $74.5M | +8.42% |
| 393 | ACET | Adicet Bio, Inc. | $73.7M | +4.73% |
| 394 | ATYR | aTyr Pharma, Inc. | $73.5M | -6.23% |
| 395 | MAIA | MAIA Biotechnology, Inc. | $72.8M | -3.23% |
| 396 | BYSI | BeyondSpring Inc. | $72.8M | +0.57% |
| 397 | QTTB | Q32 Bio Inc. | $72.0M | -10.05% |
| 398 | XBIT | XBiotech Inc. | $71.0M | -0.43% |
| 399 | PMVP | PMV Pharmaceuticals, Inc. | $70.9M | +6.40% |
| 400 | MNOV | MediciNova, Inc. | $70.4M | -0.69% |
| 401 | CING | Cingulate Inc. | $69.3M | +1.88% |
| 402 | ATHE | Alterity Therapeutics Limited | $69.1M | -1.39% |
| 403 | DWTX | Dogwood Therapeutics, Inc. | $66.1M | +2.06% |
| 404 | ICCC | ImmuCell Corporation | $65.0M | +12.70% |
| 405 | TCRX | TScan Therapeutics, Inc. | $60.3M | — |
| 406 | ACRV | Acrivon Therapeutics, Inc. | $60.0M | +1.31% |
| 407 | PDSB | PDS Biotechnology Corporation | $59.7M | +8.08% |
| 408 | OKUR | OnKure Therapeutics, Inc. | $58.5M | -2.28% |
| 409 | TIL | Instil Bio, Inc. | $57.0M | -1.59% |
| 410 | INKT | MiNK Therapeutics, Inc. | $57.0M | +2.87% |
| 411 | OSTX | OS Therapies Incorporated | $56.8M | +8.00% |
| 412 | GRCE | Grace Therapeutics, Inc. | $56.0M | +1.40% |
| 413 | HYFT | MindWalk Holdings Corp. | $55.6M | — |
| 414 | KZR | Kezar Life Sciences, Inc. | $54.2M | -0.41% |
| 415 | IMA | ImageneBio, Inc. | $53.7M | +5.03% |
| 416 | ENTX | Entera Bio Ltd. | $53.1M | -2.56% |
| 417 | EDSA | Edesa Biotech, Inc. | $52.6M | -0.67% |
| 418 | RADX | Radiopharm Theranostics Limited | $52.5M | +4.24% |
| 419 | MGX | Metagenomi Therapeutics, Inc. | $52.3M | — |
| 420 | MREO | Mereo BioPharma Group plc | $51.1M | +0.25% |
| 421 | XLO | Xilio Therapeutics, Inc. | $49.5M | -1.50% |
| 422 | ALGS | Aligos Therapeutics, Inc. | $49.3M | -0.25% |
| 423 | NTRB | Nutriband Inc. | $48.5M | +1.79% |
| 424 | ANVS | Annovis Bio, Inc. | $45.9M | -29.57% |
| 425 | LSTA | Lisata Therapeutics, Inc. | $45.2M | — |
| 426 | ACTU | Actuate Therapeutics, Inc. | $44.8M | -1.56% |
| 427 | RNXT | RenovoRx, Inc. | $44.1M | +4.20% |
| 428 | HOWL | Werewolf Therapeutics, Inc. | $43.7M | -8.74% |
| 429 | RLYB | Rallybio Corporation | $43.4M | -0.12% |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | $43.3M | -5.26% |
| 431 | RNTX | Rein Therapeutics Inc. | $42.9M | -2.55% |
| 432 | ATOS | Atossa Therapeutics, Inc. | $42.9M | +3.32% |
| 433 | IMMP | Immutep Limited | $42.6M | -8.91% |
| 434 | LITS | Lite Strategy, Inc. | $42.5M | +2.63% |
| 435 | SNSE | Sensei Biotherapeutics, Inc. | $40.9M | -3.72% |
| 436 | NXTC | NextCure, Inc. | $40.9M | +2.82% |
| 437 | ATRA | Atara Biotherapeutics, Inc. | $39.5M | -3.59% |
| 438 | CELU | Celularity Inc. | $39.2M | -0.73% |
| 439 | VERU | Veru Inc. | $39.0M | -4.71% |
| 440 | CRVO | CervoMed Inc. | $37.3M | -0.25% |
| 441 | HYPD | Hyperion DeFi, Inc. | $37.3M | +1.87% |
| 442 | PASG | Passage Bio, Inc. | $35.9M | +20.45% |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | $35.5M | -2.56% |
| 444 | ABVC | ABVC BioPharma, Inc. | $35.3M | +0.70% |
| 445 | CVM | CEL-SCI Corporation | $34.6M | -2.51% |
| 446 | EVAX | Evaxion A/S | $34.3M | +1.23% |
| 447 | PLUR | Pluri Inc. | $34.1M | +0.89% |
| 448 | INMB | INmune Bio Inc. | $34.0M | -0.78% |
| 449 | LIXT | Lixte Biotechnology Holdings, Inc. | $33.7M | +1.75% |
| 450 | LGVN | Longeveron Inc. | $32.5M | -1.77% |
| 451 | BCTX | BriaCell Therapeutics Corp. | $32.0M | +2.48% |
| 452 | DYAI | Dyadic International, Inc. | $31.9M | -1.89% |
| 453 | APLM | Apollomics, Inc. | $31.9M | -3.57% |
| 454 | PTN | Palatin Technologies, Inc. | $30.8M | -5.41% |
| 455 | MRKR | Marker Therapeutics, Inc. | $29.2M | +19.86% |
| 456 | KYNB | Kyntra Bio, Inc. | $29.1M | -1.51% |
| 457 | IGC | IGC Pharma, Inc. | $28.8M | +7.50% |
| 458 | CUE | Cue Biopharma, Inc. | $28.6M | +6.98% |
| 459 | TVRD | Tvardi Therapeutics, Inc. | $27.8M | -2.95% |
| 460 | SNTI | Senti Biosciences, Inc. | $26.9M | +1.54% |
| 461 | DARE | Daré Bioscience, Inc. | $26.9M | — |
| 462 | PSTV | Plus Therapeutics, Inc. | $26.9M | +23.66% |
| 463 | XCUR | Exicure, Inc. | $26.1M | +1.74% |
| 464 | NRSN | NeuroSense Therapeutics Ltd. | $25.8M | +1.25% |
| 465 | BOLD | Boundless Bio, Inc. | $25.5M | -0.43% |
| 466 | NEUP | Neuphoria Therapeutics Inc. | $25.4M | +0.43% |
| 467 | SER | Serina Therapeutics, Inc. | $24.6M | -0.99% |
| 468 | TVGN | Tevogen Bio Holdings Inc. | $24.4M | +0.86% |
| 469 | SKYE | Skye Bioscience, Inc. | $24.2M | +2.63% |
| 470 | OTLK | Outlook Therapeutics, Inc. | $23.3M | -11.16% |
| 471 | JSPR | Jasper Therapeutics, Inc. | $23.1M | +16.48% |
| 472 | NNVC | NanoViricides, Inc. | $22.9M | -3.64% |
| 473 | TPST | Tempest Therapeutics, Inc. | $22.7M | +1.28% |
| 474 | LEXX | Lexaria Bioscience Corp. | $22.5M | -5.27% |
| 475 | BRNS | Barinthus Biotherapeutics plc | $22.5M | -6.65% |
| 476 | VTGN | Vistagen Therapeutics, Inc. | $22.0M | +1.04% |
| 477 | AEON | AEON Biopharma, Inc. | $21.0M | -7.78% |
| 478 | LTRN | Lantern Pharma Inc. | $21.0M | -3.61% |
| 479 | QNTM | Quantum BioPharma Ltd. | $20.8M | -11.14% |
| 480 | VYNE | VYNE Therapeutics Inc. | $20.4M | +0.41% |
| 481 | CRIS | Curis, Inc. | $20.4M | -6.58% |
| 482 | COCP | Cocrystal Pharma, Inc. | $19.7M | -0.69% |
| 483 | CTXR | Citius Pharmaceuticals, Inc. | $18.9M | +1.58% |
| 484 | ALLR | Allarity Therapeutics, Inc. | $18.2M | -0.86% |
| 485 | KTTA | Pasithea Therapeutics Corp. | $18.0M | -6.01% |
| 486 | PLRZ | Polyrizon Ltd. | $17.4M | -4.87% |
| 487 | OSRH | OSR Holdings, Inc. | $16.9M | +3.80% |
| 488 | ICU | SeaStar Medical Holding Corporation | $16.2M | -2.87% |
| 489 | HIND | Vyome Holdings, Inc. | $16.1M | +7.98% |
| 490 | GNTA | Genenta Science S.p.A. | $16.0M | -4.03% |
| 491 | LPCN | Lipocine Inc. | $15.3M | -1.88% |
| 492 | PHIO | Phio Pharmaceuticals Corp. | $14.5M | -3.85% |
| 493 | INTS | Intensity Therapeutics, Inc. | $14.2M | +1.82% |
| 494 | INAB | IN8bio, Inc. | $14.0M | -2.07% |
| 495 | JUNS | Jupiter Neurosciences, Inc. | $13.9M | +2.93% |
| 496 | MBRX | Moleculin Biotech, Inc. | $13.6M | +4.94% |
| 497 | CYCN | Cyclerion Therapeutics, Inc. | $13.3M | +9.34% |
| 498 | BCDA | BioCardia, Inc. | $12.8M | -3.31% |
| 499 | CVKD | Cadrenal Therapeutics, Inc. | $12.5M | +2.47% |
| 500 | GTBP | GT Biopharma, Inc. | $12.3M | -3.56% |
| 501 | CMMB | Chemomab Therapeutics Ltd. | $12.0M | -2.34% |
| 502 | IMNN | Imunon, Inc. | $12.0M | -2.24% |
| 503 | TRAW | Traws Pharma, Inc. | $12.0M | -3.85% |
| 504 | KAPA | Kairos Pharma, Ltd. | $12.0M | -3.80% |
| 505 | CLRB | Cellectar Biosciences, Inc. | $12.0M | +2.17% |
| 506 | GDTC | CytoMed Therapeutics Limited | $11.8M | — |
| 507 | TOVX | Theriva Biologics, Inc. | $11.8M | -13.40% |
| 508 | GNPX | Genprex, Inc. | $11.8M | -0.76% |
| 509 | SNGX | Soligenix, Inc. | $11.8M | -0.87% |
| 510 | BLRX | BioLineRx Ltd. | $11.1M | -0.87% |
| 511 | KPRX | Kiora Pharmaceuticals, Inc. | $10.9M | -13.29% |
| 512 | BIVI | BioVie Inc. | $10.9M | -3.36% |
| 513 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | $10.8M | +6.96% |
| 514 | QNRX | Quoin Pharmaceuticals, Ltd. | $10.3M | -4.17% |
| 515 | HOTH | Hoth Therapeutics, Inc. | $10.3M | -4.04% |
| 516 | CALC | CalciMedica, Inc. | $10.3M | +4.49% |
| 517 | ELAB | PMGC Holdings Inc. | $10.2M | +16.89% |
| 518 | LNAI | Lunai Bioworks Inc. | $10.0M | +15.99% |
| 519 | NCEL | NewcelX Ltd. | $9.5M | -1.88% |
| 520 | LIMN | Liminatus Pharma, Inc. | $9.2M | +11.96% |
| 521 | NCNA | NuCana plc | $8.7M | +10.53% |
| 522 | BOLT | Bolt Biotherapeutics, Inc. | $8.7M | -1.96% |
| 523 | APRE | Aprea Therapeutics, Inc. | $8.4M | +4.62% |
| 524 | EVGN | Evogene Ltd. | $8.1M | +2.10% |
| 525 | PCSA | Processa Pharmaceuticals, Inc. | $7.9M | -1.66% |
| 526 | RNAZ | TransCode Therapeutics, Inc. | $7.8M | +2.27% |
| 527 | ACXP | Acurx Pharmaceuticals, Inc. | $7.7M | -9.12% |
| 528 | CELZ | Creative Medical Technology Holdings, Inc. | $7.5M | -7.69% |
| 529 | BCAB | BioAtla, Inc. | $7.5M | +1.80% |
| 530 | GRDX | GridAI Technologies Corp. | $7.3M | +4.81% |
| 531 | XBIO | Xenetic Biosciences, Inc. | $7.2M | +3.28% |
| 532 | PMCB | PharmaCyte Biotech, Inc. | $7.2M | -1.37% |
| 533 | ADXN | Addex Therapeutics Ltd | $7.0M | +7.89% |
| 534 | QNCX | Quince Therapeutics, Inc. | $6.9M | -32.44% |
| 535 | CANF | Can-Fite BioPharma Ltd. | $6.8M | -4.87% |
| 536 | APM | Aptorum Group Limited | $6.8M | -2.84% |
| 537 | SILO | Silo Pharma, Inc. | $6.8M | -5.90% |
| 538 | TCRT | Alaunos Therapeutics, Inc. | $6.7M | -2.75% |
| 539 | FBLG | FibroBiologics, Inc. | $6.3M | -1.43% |
| 540 | IMRN | Immuron Limited | $6.2M | — |
| 541 | XTLB | XTL Biopharmaceuticals Ltd. | $6.2M | +5.98% |
| 542 | BRTX | BioRestorative Therapies, Inc. | $6.1M | -6.54% |
| 543 | PPBT | Purple Biotech Ltd | $6.1M | -6.86% |
| 544 | MTVA | MetaVia Inc. | $6.1M | -3.25% |
| 545 | ASBP | Aspire Biopharma Holdings, Inc. | $6.0M | +0.84% |
| 546 | ERNA | Ernexa Therapeutics Inc. | $6.0M | -6.32% |
| 547 | MLEC | Moolec Science SA | $5.9M | -10.09% |
| 548 | PBM | Psyence Biomedical Ltd. | $5.7M | +0.40% |
| 549 | MBIO | Mustang Bio, Inc. | $5.6M | -0.93% |
| 550 | BGMS | Bio Green Med Solution, Inc. | $5.6M | +2.02% |
| 551 | CLGN | CollPlant Biotechnologies Ltd. | $5.5M | +13.27% |
| 552 | CDIO | Cardio Diagnostics Holdings, Inc. | $5.4M | -10.84% |
| 553 | KALA | KALA BIO, Inc. | $5.2M | +2.92% |
| 554 | GLMD | Galmed Pharmaceuticals Ltd. | $5.2M | +26.15% |
| 555 | APVO | Aptevo Therapeutics Inc. | $5.2M | +2.10% |
| 556 | ARTL | Artelo Biosciences, Inc. | $5.1M | -4.82% |
| 557 | DRMA | Dermata Therapeutics, Inc. | $4.9M | -5.47% |
| 558 | PHGE | BiomX Inc. | $4.8M | +3.10% |
| 559 | JAGX | Jaguar Health, Inc. | $4.7M | -5.01% |
| 560 | PULM | Pulmatrix, Inc. | $4.6M | +5.88% |
| 561 | SXTP | 60 Degrees Pharmaceuticals, Inc. | $4.6M | -3.87% |
| 562 | REVB | Revelation Biosciences, Inc. | $4.6M | +1.65% |
| 563 | ENSC | Ensysce Biosciences, Inc. | $4.5M | -2.22% |
| 564 | AKTX | Akari Therapeutics, Plc | $4.3M | -1.93% |
| 565 | AIM | AIM ImmunoTech Inc. | $4.2M | -6.24% |
| 566 | INDP | Indaptus Therapeutics, Inc. | $4.2M | +17.83% |
| 567 | VIVS | VivoSim Labs, Inc. | $4.0M | -3.16% |
| 568 | ENVB | Enveric Biosciences, Inc. | $3.9M | +4.08% |
| 569 | AZTR | Azitra, Inc. | $3.8M | -0.47% |
| 570 | SLXN | Silexion Therapeutics Corp | $3.7M | -0.89% |
| 571 | ALZN | Alzamend Neuro, Inc. | $3.4M | -3.08% |
| 572 | GRI | GRI Bio, Inc. | $3.4M | -1.67% |
| 573 | MTNB | Matinas BioPharma Holdings, Inc. | $3.2M | +3.04% |
| 574 | DCOY | Decoy Therapeutics Inc. | $3.2M | +6.57% |
| 575 | GOVX | GeoVax Labs, Inc. | $3.0M | -1.69% |
| 576 | CLDI | Calidi Biotherapeutics, Inc. | $2.9M | +3.75% |
| 577 | OGEN | Oragenics, Inc. | $2.7M | +3.51% |
| 578 | CMND | Clearmind Medicine Inc. | $2.5M | -8.40% |
| 579 | HCWB | HCW Biologics Inc. | $2.3M | +2.77% |
| 580 | BBLG | Bone Biologics Corporation | $2.3M | -1.56% |
| 581 | ADIL | Adial Pharmaceuticals, Inc. | $2.2M | -5.45% |
| 582 | BDRX | Biodexa Pharmaceuticals Plc | $2.1M | -7.41% |
| 583 | PPCB | Propanc Biopharma, Inc. | $2.1M | -20.32% |
| 584 | SCNI | Scinai Immunotherapeutics Ltd. | $2.0M | +1.79% |
| 585 | SPRC | SciSparc Ltd. | $1.7M | -10.53% |
| 586 | CNSP | CNS Pharmaceuticals, Inc. | $1.7M | -2.29% |
| 587 | CDT | CDT Equity Inc. | $1.0M | +15.04% |
| 588 | VRAX | Virax Biolabs Group Limited | $1.0M | -10.07% |
| 589 | ONCO | Onconetix, Inc. | $845,370 | +7.96% |
| 590 | ADTX | Aditxt, Inc. | $479,370 | +1.92% |